Research Funding

 

High-Risk Research: NIH Director's Early Independence Award Program

Title NIH Guide RFA Number Common Fund Contact Application
Receipt Date
2022 NIH Director's Early Independence Award (DP5) 4/26/2021 RFA-RM-21-018 Becky Miller
EarlyIndependence@mail.nih.gov
301-435-7204
Letter of Intent:
8/3/2021
Receipt Date:
9/3/2021
Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed) 11/16/2020 PA-21-071 Becky Miller
earlyindependence@mail.nih.gov
301-594-9979
 
Research Supplements to Promote Re-Entry into Biomedical and Behavioral Research Careers (Admin Supp - Clinical Trial Not Allowed) 1/25/2018 PA-18-592 Becky Miller
earlyindependence@mail.nih.gov
301-594-9979
 

High-Risk Research: NIH Director's New Innovator Award Program

Title NIH Guide RFA Number Common Fund Contact Application
Receipt Date
2022 NIH Director's New Innovator Award Program (DP2 Clinical Trial Optional) 5/20/2021 RFA-RM-21-016 Ravi Basavappa,
NewInnovatorAwards@mail.nih.gov
301 435-7204
8/20/2021
Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed) 11/16/2020 PA-21-071 Ravi Basavappa
NewInnovatorAward@mail.nih.gov
(301) 435-7204
 
Research Supplements to Promote Re-Entry into Biomedical and Behavioral Research Careers (Admin Supp - Clinical Trial Not Allowed) 1/25/2018 PA-18-592 Ravi Basavappa
NewInnovatorAward@mail.nih.gov
301 435-7204
 


High-Risk Research: NIH Director's Pioneer Award Program

Title NIH Guide RFA Number Common Fund Contact Application
Receipt Date
2022 NIH Director’s Pioneer Award Program (DP1 Clinical Trial Optional) 4/6/2021 RFA-RM-21-015 Ravi Basavappa
PioneerAwards@mail.nih.gov
301-435-7204
9/10/2021
Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed) 11/16/2020 PA-21-071 Ravi Basavappa
PioneerAwards@mail.nih.gov
(301) 435-7204
 
Research Supplements to Promote Re-Entry into Biomedical and Behavioral Research Careers (Admin Supp - Clinical Trial Not Allowed) 1/25/2018 PA-18-592 Ravi Basavappa
PioneerAwards@mail.nih.gov
301 435-7204
 


High-Risk Research: NIH Director's Transformative Award Program

Title NIH Guide RFA Number Common Fund Contact Application
Receipt Date
2022 NIH Directors Transformative Research Awards (R01 Clinical Trial Optional) 6/4/2021 RFA-RM-21-017 Ravi Basavappa
Transformative_Awards@mail.nih.gov
(301) 435-7204
Receipt Date:
9/1/2021
Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed) 11/16/2020 PA-21-071 Ravi Basavappa
Transformative_Awards@mail.nih.gov
(301) 435-7204
 
Research Supplements to Promote Re-Entry into Biomedical and Behavioral Research Careers (Admin Supp - Clinical Trial Not Allowed) 1/25/2018 PA-18-592 Ravi Basavappa
Transformative_Awards@mail.nih.gov
(301) 435-7204
 

Illuminating the Druggable Genome Program

Title NIH Guide RFA Number Common Fund Contact Estimated
Receipt Date
Pilot Projects Investigating Understudied G Protein-Coupled Receptors, Ion Channels, and Protein Kinases (R03 Clinical Trial Not Allowed) 4/1/2021 RFA-RM-21-012 Karlie Sharma
DruggableGenome@mail.nih.gov
301-451-4965
Letter of Intent:
6/15/2021
Receipt Date:
7/15/2021
Cutting Edge Informatics Tools for Illuminating the Druggable Genome (U01 Clinical Trial Not Allowed) 4/5/2021 RFA-RM-21-020 Jerry Li
DruggableGenome@mail.nih.gov
240-276-6210
Letter of Intent:
6/15/2021
Receipt Date
7/15/2021

Bridge to Artificial Intelligence (Bridge2AI)

Title NIH Guide RFA Number Common Fund Contact Estimated
Receipt Date

Integration, Dissemination, and Evaluation (BRIDGE) Center for the NIH Bridge to Artificial Intelligence (Bridge2AI) Program (U54 Clinical Trial Not Allowed)

5/8/2021 RFA-RM-21-023 Shurjo Sen
bridge2ai@od.nih.gov
301-827-7028
Letters of Intent:
30 days prior to the application due date
Receipt Date:
8/20/2021
Data Generation Projects for the NIH Bridge to Artificial Intelligence (Bridge2AI) Program (OT2) 5/12/2021 OTA-21-008 Shurjo Sen
bridge2ai@od.nih.gov
301-827-7028
Letters of Intent:
7/ 20/2021
Full proposals: 8/20/2021

 

 

Past Funding Opportunities

This page last reviewed on June 21, 2021